These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21628088)

  • 21. Raman mapping of low-content active-ingredient pharmaceutical formulations. part II: statistically optimized sampling for detection of less than 1% of an active pharmaceutical ingredient.
    Sasić S; Whitlock M
    Appl Spectrosc; 2008 Aug; 62(8):916-21. PubMed ID: 18702866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of water in the physical stability of solid dosage formulations.
    Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
    J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy.
    Tian F; Zhang F; Sandler N; Gordon KC; McGoverin CM; Strachan CJ; Saville DJ; Rades T
    Eur J Pharm Biopharm; 2007 Jun; 66(3):466-74. PubMed ID: 17257816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raman microscopic evaluation of technology dependent structural differences in tablets containing imipramine model drug.
    Vajna B; Farkas I; Szabó A; Zsigmond Z; Marosi G
    J Pharm Biomed Anal; 2010 Jan; 51(1):30-8. PubMed ID: 19709837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of high sensitivity micro differential scanning calorimetry with X-ray powder diffractometry and FTIR spectroscopy for the characterization of pharmaceutically relevant non-crystalline materials.
    Song M; Liebenberg W; De Villiers MM
    Pharmazie; 2006 Apr; 61(4):336-40. PubMed ID: 16649550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raman mapping of pharmaceuticals.
    Gordon KC; McGoverin CM
    Int J Pharm; 2011 Sep; 417(1-2):151-62. PubMed ID: 21194560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.
    Cooper VB; Pearce GE; Petts CR
    J Pharm Pharmacol; 2003 Sep; 55(9):1323-9. PubMed ID: 14604477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical imaging of pharmaceutical granules by Raman global illumination and near-infrared mapping platforms.
    Sasić S
    Anal Chim Acta; 2008 Mar; 611(1):73-9. PubMed ID: 18298970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SEM/EDX and confocal Raman microscopy as complementary tools for the characterization of pharmaceutical tablets.
    Scoutaris N; Vithani K; Slipper I; Chowdhry B; Douroumis D
    Int J Pharm; 2014 Aug; 470(1-2):88-98. PubMed ID: 24836664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and quantitative determination of atorvastatin calcium polymorph in tablets using FT-Raman spectroscopy.
    Skorda D; Kontoyannis CG
    Talanta; 2008 Jan; 74(4):1066-70. PubMed ID: 18371751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of pharmaceutical tablets by Raman spectroscopy and chemometrics.
    Roggo Y; Degardin K; Margot P
    Talanta; 2010 May; 81(3):988-95. PubMed ID: 20298883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of various excipients on the conversion kinetics of carbamazepine polymorphs in aqueous suspension.
    Tian F; Saville DJ; Gordon KC; Strachan CJ; Zeitler JA; Sandler N; Rades T
    J Pharm Pharmacol; 2007 Feb; 59(2):193-201. PubMed ID: 17270073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of different chemometric methods to extract chemical and physical information from Raman images of homogeneous and heterogeneous semi-solid pharmaceutical formulations.
    Mitsutake H; Castro SR; de Paula E; Poppi RJ; Rutledge DN; Breitkreitz MC
    Int J Pharm; 2018 Dec; 552(1-2):119-129. PubMed ID: 30266516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cohesive, multicomponent, dense powder flow characterization by NIR.
    Benedetti C; Abatzoglou N; Simard JS; McDermott L; Léonard G; Cartilier L
    Int J Pharm; 2007 May; 336(2):292-301. PubMed ID: 17240094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermal analysis: a further step in characterizing solid forms obtained by screening crystallization of an API.
    Detoisien T; Arnoux M; Taulelle P; Colson D; Klein JP; Veesler S
    Int J Pharm; 2011 Jan; 403(1-2):29-36. PubMed ID: 20951782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions.
    Ivanisevic I; Bates S; Chen P
    J Pharm Sci; 2009 Sep; 98(9):3373-86. PubMed ID: 19283767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical characterization of cyclodextrin-drug interactions in the solid state and the effect of water on these interactions.
    Ogawa N; Takahashi C; Yamamoto H
    J Pharm Sci; 2015 Mar; 104(3):942-54. PubMed ID: 25581322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
    Maghsoodi M; Tajalli Bakhsh AS
    Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study.
    Német Z; Kis GC; Pokol G; Demeter A
    J Pharm Biomed Anal; 2009 Feb; 49(2):338-46. PubMed ID: 19131203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.